Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · IEX Real-Time Price · USD
21.82
-0.20 (-0.91%)
At close: Jul 19, 2024, 4:00 PM
21.46
-0.36 (-1.65%)
Pre-market: Jul 22, 2024, 8:11 AM EDT
Fulgent Genetics Employees
Fulgent Genetics had 1,184 employees as of December 31, 2023. The number of employees increased by 172 or 17.00% compared to the previous year.
Employees
1,184
Change (1Y)
172
Growth (1Y)
17.00%
Revenue / Employee
$242,846
Profits / Employee
-$140,158
Market Cap
652.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aveanna Healthcare Holdings | 33,500 |
| Definitive Healthcare | 830 |
| Paragon 28 | 574 |
| Exscientia | 483 |
| Phathom Pharmaceuticals | 452 |
| UroGen Pharma | 201 |
| Arcturus Therapeutics Holdings | 180 |
| Acelyrin | 135 |
FLGT News
- 10 days ago - Fulgent to Announce Second Quarter 2024 Financial Results on Friday, August 2, 2024 - Business Wire
- 6 weeks ago - Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing - GlobeNewsWire
- 7 weeks ago - Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer - Business Wire
- 2 months ago - Fulgent Announces Upcoming Presentation of Clinical Data for Its Lead Therapeutic Oncology Candidate, FID-007, at ASCO 2024 Annual Meeting - Business Wire
- 2 months ago - Moffitt Cancer Center and Fulgent Pharma Join Forces to Revolutionize Cancer Therapeutics - Business Wire
- 2 months ago - Fulgent Reports First Quarter 2024 Financial Results - Business Wire
- 3 months ago - Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024 - Business Wire
- 5 months ago - Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results - Business Wire